Addus HomeCare (ADUS) Competitors $115.68 +1.49 (+1.30%) Closing price 04:00 PM EasternExtended Trading$115.64 -0.04 (-0.03%) As of 04:25 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock ADUS vs. GH, OPCH, RDNT, SHC, BTSG, SGRY, WGS, CON, PRVA, and VCYTShould you be buying Addus HomeCare stock or one of its competitors? The main competitors of Addus HomeCare include Guardant Health (GH), Option Care Health (OPCH), RadNet (RDNT), Sotera Health (SHC), BrightSpring Health Services (BTSG), Surgery Partners (SGRY), GeneDx (WGS), Concentra Group Holdings Parent (CON), Privia Health Group (PRVA), and Veracyte (VCYT). These companies are all part of the "healthcare" industry. Addus HomeCare vs. Its Competitors Guardant Health Option Care Health RadNet Sotera Health BrightSpring Health Services Surgery Partners GeneDx Concentra Group Holdings Parent Privia Health Group Veracyte Addus HomeCare (NASDAQ:ADUS) and Guardant Health (NASDAQ:GH) are both mid-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their valuation, media sentiment, dividends, analyst recommendations, risk, earnings, profitability and institutional ownership. Does the media favor ADUS or GH? In the previous week, Guardant Health had 2 more articles in the media than Addus HomeCare. MarketBeat recorded 14 mentions for Guardant Health and 12 mentions for Addus HomeCare. Guardant Health's average media sentiment score of 1.07 beat Addus HomeCare's score of 0.89 indicating that Guardant Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Addus HomeCare 6 Very Positive mention(s) 3 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Guardant Health 8 Very Positive mention(s) 1 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more risk and volatility, ADUS or GH? Addus HomeCare has a beta of 0.8, indicating that its stock price is 20% less volatile than the S&P 500. Comparatively, Guardant Health has a beta of 1.43, indicating that its stock price is 43% more volatile than the S&P 500. Do analysts rate ADUS or GH? Addus HomeCare currently has a consensus target price of $138.63, indicating a potential upside of 19.83%. Guardant Health has a consensus target price of $57.50, indicating a potential downside of 1.83%. Given Addus HomeCare's higher probable upside, equities analysts plainly believe Addus HomeCare is more favorable than Guardant Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Addus HomeCare 1 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 2 Strong Buy rating(s) 3.00Guardant Health 0 Sell rating(s) 0 Hold rating(s) 16 Buy rating(s) 1 Strong Buy rating(s) 3.06 Is ADUS or GH more profitable? Addus HomeCare has a net margin of 6.51% compared to Guardant Health's net margin of -49.93%. Addus HomeCare's return on equity of 9.39% beat Guardant Health's return on equity.Company Net Margins Return on Equity Return on Assets Addus HomeCare6.51% 9.39% 6.86% Guardant Health -49.93%N/A -28.95% Do institutionals & insiders hold more shares of ADUS or GH? 95.3% of Addus HomeCare shares are owned by institutional investors. Comparatively, 92.6% of Guardant Health shares are owned by institutional investors. 4.5% of Addus HomeCare shares are owned by company insiders. Comparatively, 6.1% of Guardant Health shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Which has better valuation & earnings, ADUS or GH? Addus HomeCare has higher revenue and earnings than Guardant Health. Guardant Health is trading at a lower price-to-earnings ratio than Addus HomeCare, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAddus HomeCare$1.27B1.67$73.60M$4.5325.54Guardant Health$739.02M9.88-$436.37M-$3.35-17.48 SummaryAddus HomeCare beats Guardant Health on 10 of the 17 factors compared between the two stocks. Get Addus HomeCare News Delivered to You Automatically Sign up to receive the latest news and ratings for ADUS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ADUS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ADUS vs. The Competition Export to ExcelMetricAddus HomeCareMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.13B$5.33B$5.76B$9.65BDividend YieldN/A1.25%3.91%4.09%P/E Ratio25.5426.4730.7825.12Price / Sales1.67136.48456.64116.46Price / Cash21.3626.5625.2228.45Price / Book2.164.499.375.95Net Income$73.60M$189.47M$3.26B$265.46M7 Day Performance2.32%1.13%1.88%0.96%1 Month Performance8.08%14.69%3.73%2.47%1 Year Performance-12.40%13.19%28.93%20.24% Addus HomeCare Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ADUSAddus HomeCare4.7708 of 5 stars$115.68+1.3%$138.63+19.8%-13.1%$2.13B$1.27B25.5449,703Analyst ForecastGHGuardant Health3.1718 of 5 stars$54.80+1.1%$57.50+4.9%+112.8%$6.76B$739.02M-16.362,021Positive NewsOPCHOption Care Health4.6587 of 5 stars$27.85-1.2%$35.75+28.4%-10.1%$4.58B$5.00B19.588,088News CoveragePositive NewsRDNTRadNet3.3201 of 5 stars$62.00+16.2%$69.60+12.3%+2.9%$4.00B$1.83B-144.1811,021News CoverageAnalyst UpgradeHigh Trading VolumeSHCSotera Health1.1975 of 5 stars$14.06+0.6%$16.00+13.8%+5.5%$3.97B$1.10B22.173,000Analyst UpgradeHigh Trading VolumeBTSGBrightSpring Health Services2.633 of 5 stars$20.66-0.6%$25.67+24.2%+92.3%$3.68B$11.27B28.0835,000Positive NewsSGRYSurgery Partners3.09 of 5 stars$22.74-3.8%$33.00+45.1%-22.5%$3.03B$3.11B-15.9015,000WGSGeneDx2.2931 of 5 stars$110.54+5.1%$101.63-8.1%+264.2%$3.02B$305.45M2,210.801,200CONConcentra Group Holdings Parent2.3223 of 5 stars$21.47-0.7%$28.50+32.7%-2.4%$2.77B$1.90B17.5811,250News CoveragePositive NewsPRVAPrivia Health Group3.4579 of 5 stars$20.31-1.3%$28.00+37.9%+7.4%$2.53B$1.74B184.651,140VCYTVeracyte2.9286 of 5 stars$27.99+2.3%$40.90+46.1%-8.5%$2.15B$445.76M84.82790Positive News Related Companies and Tools Related Companies Guardant Health Alternatives Option Care Health Alternatives RadNet Alternatives Sotera Health Alternatives BrightSpring Health Services Alternatives Surgery Partners Alternatives GeneDx Alternatives Concentra Group Holdings Parent Alternatives Privia Health Group Alternatives Veracyte Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ADUS) was last updated on 8/19/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Addus HomeCare Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Addus HomeCare With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access